Sign in

CIK 0000073290 · Non-accelerated filer<br>Smaller reporting company

BIOMERICA INC

Sign in to watch
Ticker
BMRA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
May 31
Incorporated
DE
Entity type
operating
EIN
952645573
Phone
9493792875
Business address
17571 VON KARMAN AVENUE, IRVINE, CA, 92614
  1. 4 Option exercise Director acquired 20,000 shares (option exercise)
  2. 4 Option exercise Secretary acquired 35,000 shares (option exercise)
  3. 4 Option exercise Chief Executive Officer acquired 50,000 shares (option exercise)
  4. 10-Q Report Quarterly Report
  5. 4 Option exercise Director acquired 20,000 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 8-K Event Other events
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 10-Q Report Quarterly Report
  15. 4 Open-market buy Chief Executive Officer bought 2,000 shares at $1.04 ($2,080)
  16. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $0.83 ($4,150)
  17. 10-Q Report Quarterly Report
  18. DEF 14A Proxy Proxy Statement
  19. 10-K Report Annual Report
  20. 4/A Open-market buy Chief Executive Officer bought 3,000 shares at $1.08 ($3,240)

Page 17 of 31 · 605 filings